Aaron Gerds, MD, MS, provides an overview of myelofibrosis and its changing treatment landscape.
EP. 1: Overview of Myelofibrosis Types and Presentations
Aaron Gerds, MD, MS, explains the types, presentations, and classic symptoms of myelofibrosis.
EP. 2: Myelofibrosis: Molecular Pathways and Prognostic Factors
An expert on hematologic malignancies discusses the prognostic factors and molecular pathways involved in myelofibrosis.
EP. 3: Approved Therapies for Myelofibrosis
A comprehensive overview of ruxolitinib, fedratinib, and pacritinib, the approved therapies for the treatment of myelofibrosis.
EP. 4: Potential Role of Momelotinib in Myelofibrosis
Aaron Gerds, MD, MS, discusses the MOMENTUM study and the potential role of momelotinib in the myelofibrosis treatment landscape.
EP. 5: Treatment Sequencing Considerations in Myelofibrosis
An expert oncologist overviews quality-of-life data and considerations in treatment sequencing in myelofibrosis.
EP. 6: Emerging Research in Myelofibrosis Treatment
A thorough review of promising therapies currently under investigation for the treatment of myelofibrosis.
EP. 7: Closing Remarks on the Future Treatment Landscape of Myelofibrosis
Aaron Gerds, MD, MS, offers closing remarks on the outlook for the treatment of myelofibrosis, and shares advice for community oncologists.
2 Clarke Drive Cranbury, NJ 08512